Engineered biological entities for drug delivery and gene therapy protein nanoparticles.
about
Random mutagenesis of amelogenin for engineering protein nanoparticles.Temporal techniques: dynamic tracking of nanomaterials in live cells.Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy.In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles.
P2860
Engineered biological entities for drug delivery and gene therapy protein nanoparticles.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Engineered biological entities for drug delivery and gene therapy protein nanoparticles.
@en
Engineered biological entities for drug delivery and gene therapy protein nanoparticles.
@nl
type
label
Engineered biological entities for drug delivery and gene therapy protein nanoparticles.
@en
Engineered biological entities for drug delivery and gene therapy protein nanoparticles.
@nl
prefLabel
Engineered biological entities for drug delivery and gene therapy protein nanoparticles.
@en
Engineered biological entities for drug delivery and gene therapy protein nanoparticles.
@nl
P50
P921
P1476
Engineered biological entities for drug delivery and gene therapy protein nanoparticles
@en
P2093
Escarlata Rodríguez-Carmona
P304
P356
10.1016/B978-0-12-416020-0.00006-1
P577
2011-01-01T00:00:00Z